Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IOVA | IBRX | FTRE | ||
| Company | Iovance Biotherapeutics Inc | Immunitybio Inc | Fortrea Holdings Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 11.60 | 4.91 | 35.88 | ||
| High | 11.69 | 5.30 | 36.28 | ||
| Low | 11.01 | 4.82 | 35.30 | ||
| Last | 11.31 | 5.27 | 35.50 | ||
| Change | -0.41 | +0.36 | -0.50 | ||
| % Change | -3.50% | +7.33% | -1.39% | ||
| Volume | 5,263,500 | 4,560,100 | 1,111,000 | ||
| 20-Day Average Volume | 4,595,450 | 4,112,755 | 717,370 | ||
| Previous Close | 11.72 | 4.91 | 36.00 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 13.23 | 5.51 | 38.58 | ||
| 20-Day Raw Stochastic | 6.68% | 31.05% | 3.75% | ||
| 20-Day Relative Strength | 39.73% | 50.41% | 40.77% | ||
| Weighted Alpha | +21.85 | -17.34 | +19.98 | ||
| Today's Opinion | 40% Buy | 80% Buy | 56% Buy | ||
| Previous Opinion | 40% Buy | 64% Buy | 56% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.50% since 04/12/24 | +3.13% since 04/12/24 | -9.09% since 04/12/24 | ||
| Low | 11.01 on 04/19/24 | 4.76 on 04/17/24 | 35.30 on 04/19/24 | ||
| High | 12.53 on 04/15/24 | 5.55 on 04/15/24 | 39.49 on 04/15/24 | ||
| 1-Month | |||||
| %Chg | -18.63% since 03/19/24 | -2.95% since 03/19/24 | -10.44% since 03/19/24 | ||
| Low | 11.01 on 04/19/24 | 4.59 on 03/27/24 | 35.30 on 04/19/24 | ||
| High | 15.90 on 03/21/24 | 6.78 on 03/22/24 | 41.02 on 03/21/24 | ||
| 3-Month | |||||
| %Chg | +45.37% since 01/19/24 | +46.39% since 01/19/24 | +15.75% since 01/19/24 | ||
| Low | 7.34 on 01/29/24 | 3.12 on 01/25/24 | 30.16 on 02/05/24 | ||
| High | 18.33 on 02/28/24 | 6.78 on 03/22/24 | 41.02 on 03/21/24 | ||
| 6-Month | |||||
| %Chg | +242.73% since 10/19/23 | +319.92% since 10/19/23 | +21.83% since 10/19/23 | ||
| Low | 3.27 on 10/20/23 | 1.27 on 10/20/23 | 26.81 on 10/26/23 | ||
| High | 18.33 on 02/28/24 | 6.78 on 03/22/24 | 41.02 on 03/21/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,273,478 | 3,324,085 | 3,217,464 | ||
| Shares Outstanding, K | 279,307 | 677,003 | 89,374 | ||
| Annual Sales | 1,190,000 | 620,000 | 3,109,000,000 | ||
| Annual Net Income | -444,040,000 | -583,200,000 | -3,400,000 | ||
| Last Quarter Sales | 480,000 | 140,000 | 775,400,000 | ||
| Last Quarter Net Income | -116,380,000 | -233,390,000 | -36,000,000 | ||
| 60-Month Beta | 0.62 | 1.23 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.45 on 02/28/24 | -0.19 on 03/19/24 | 0.19 on 03/11/24 | ||
| Latest Earnings Date | 05/14/24 | 05/09/24 | 05/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||